Synopsis: Investec maintained a Buy rating on Varun Beverages with a ₹609 target price, citing growth opportunities from its Asahi partnership and expanded beverage portfolio. This Large-cap Stock, engaged in manufacturing, bottling, distributing, and selling PepsiCo...
Synopsis: GE Vernova T&D’s ₹21,500 crore order backlog and strong earnings growth support its ₹6,000 target, though valuation concerns and margin risks may limit upside. This Large-cap stock, engaged in providing transmission equipment, grid automation solutions,...
Synopsis: Tata Motors targets strong PV growth with EV-led expansion, aiming to double volumes, reach 20% market share by FY31, and improve profitability through scale, cost control, and wider product portfolio. The shares of this large cap company majorly engaged in...
Synopsis: Defence stock gained attention after receiving a Rs 1,348 crore order from Hindustan Aeronautics Limited for the supply of missile-related systems and components. The share of this company, which is under the Ministry of Defence for the manufacturing of...
Synopsis: Vodafone Idea’s stock has rallied over 100% in the past year, driven mainly by sentiment improvement, AGR relief, and fundraising expectations. While the company shows early signs of stabilisation in subscriber trends, it still faces high debt and strong...
Synopsis:- In a move that extends its managed services footprint into the semiconductor industry, Infosys has announced an expanded multi-year collaboration with GlobalFoundries to run the chip manufacturer’s end-to-end enterprise IT operations through an AI-led...
Synopsis: The Government of India is selling up to a 2% stake in IRFC through an OFS worth about ₹2,443 crore to increase public shareholding and compliance. This Large-Cap Stock, engaged in financing and leasing railway assets, rolling stock, and infrastructure...
Synopsis: Nomura has maintained an “Accumulate” rating on Dr Reddy’s Laboratories Ltd, raising its target to ₹1,740, implying ~34% upside. The view is driven by a strategic shift toward branded drugs, improving margins, pricing power, and earnings quality. Lower...
Synopsis: Citi placed Cipla Ltd on a 90-day Positive Catalyst Watch, retaining a Buy rating with a ₹1,700 target, implying 20% upside. Growth is driven by a strong US respiratory pipeline, regulatory clearances, and recovery in India business. Earnings bottoming,...
Synopsis: Vedanta shares came under pressure after reports of a promoter stake sale through a block deal. The transaction follows the company’s recent demerger and has drawn investor attention. The shares of this large cap company majorly engaged in exploring,...
